Notably, DLL4 is a master regulator of angiogenic vascular patterning 27-35 and inhibition of DLL4 attenuates tumor growth and progression by eliciting nonproductive angiogenesis 28, 31-35, yet the explicit role of DLL4 in EPR and its influence on NP delivery and efficacy remains untested. Here, DLL4 is linked to neoplasm.